Tuesday, May 1: Monika Davare Ph.D. delivers Research Week keynote

Monika Davare, Ph.D. (Courtesy OHSU Onward)

Monika Davare’s lab focuses on overcoming the therapeutic bottleneck in rare but aggressive pediatric and adult cancers. Davare will share her latest research — and talk about her personal career path – in the Alliance for Visible Diversity in Science Keynote at Research Week.

ROS1 in cancer: From model systems to the development of novel therapeutics

Monika Davare, Ph.D.
Tuesday, May 1, 4 to 5 p.m.
OHSU Auditorium

Davare is an assistant professor of pediatrics in the OHSU School of Medicine. Her research was recognized in 2017 with a Biomedical Innovation Program Award in the drug discovery track. The award is given by the Oregon Clinical and Translational Research Institute.

In a paper published recently in Clinical Cancer Research, Davare and colleagues provided the first example of successful therapeutic intervention with targeted therapy to overcome crizotinib resistance in a ROS1-rearranged cancer.